Treatment of infantile hepatoblastoma and related complications

Tokai Journal of Experimental and Clinical Medicine

Volumn 30, Issue 4, 2005, Pages 203-209

  Ueno, Shigeru ^a   Hirakawa, Hitoshi ^a   Yokoyama, Seishichi ^a   Hinoki, Tomoya ^a   Tobita, Kosuke ^a   Ohtani, Yasuo ^a   Imaizumi, Toshihide ^a   Makuuchi, Hiroyasu ^a   Iwata, Yoshio ^a   Imai, Yutaka ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Complication; Hepatoblastoma; Infant

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PIRARUBICIN;

ANEMIA; ARTICLE; ARTIFICIAL EMBOLISM; ARTIFICIAL VENTILATION; BLEEDING; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ECHOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HEARING LOSS; HEPATOBLASTOMA; HUMAN; INFANT; LIVER RUPTURE; LOBECTOMY; LUNG EDEMA; MALE; NEUTROPENIA; PREOPERATIVE TREATMENT; PRESCHOOL CHILD; PROGNOSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; PROGNOSIS; RADIOLOGY, INTERVENTIONAL;

EID: 32844467487     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bertolini P., Lassalle M., Mercier G., Raquin M.A., Izzi G., Corradini N. and Hartmann O. Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hemato/Oncol 26: 649-655, 2004.
2. Brown J., Perilongo G., Shafford E., Keeling J., Pritchard J., Brock P., Dicks-Mireaux C., Phillips A., Vos A., Plaschkes J. Prognostic factors in childhood hepatoblastoma-results of the first prospective clinical trials of the International Society of Pediatric Oncology SIOPEL 1. Eur. J. Cancer 36: 1418-1425, 2000.
3. Chan K.L., Fan S.T., Tam P.K.H., Chiang A.K.S., Chan G.C.F., Ha S.Y. Management of spontaneously ruptured hepatoblastoma in infancy. Med Pediatr Oncol 38: 137-138, 2002.
4. Exelby P.R., Filler R.M. and Grosfeld Y.L., Liver tumors in children in particular reference to hepatoblastoma and hepatocellular carcinoma. American Academy of Paediatrics Surgical Section Survey-1974. J Pediatr Surg 10: 329-337, 1975.
5. Kitahara S., Makuuchi M., Ishizone S., Terada M., Kawasaki S., Nakahata T., Komiyama A. Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization. J Pediatr Surg 30: 1709-1712, 1995.
6. Lee S.-C., Chung J.-W., Kim K.-H., Kim W.-K. Successful transumbilical embolization of congenitally ruptured hepatoblastoma. J Pediatr Surg 34: 1851-1852, 1999.
7. Li Y., Womer R.B. and Silber J.H. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J of Cancer 40: 2445-2451, 2004.
8. Matsunaga T., Sasaki F., Ohira M., Hashizume K., Hayashi A., Hayashi Y., Mugishima H., Ohnuma N. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 19: 142-146, 2003.
9. Ohnuma N., Matsunaga T., Sasaki F., Ohira M., Hashizume K., Hayashi A., Hayashi Y., Matsuyama K., Mugishima H. New therapeutic approach for hepatoblastoma in children. Jpn J Pediatr Surg 33: 1247-1251, 2001. (Japanese with English abstract)
10. Otte J.B., Pritchard J., Aronson D.C., Brown J., Czauderna P., Maibach R., Perilongo G., Shafford E. and Plaschkes J. Liver Transplantation for Hepatoblastoma: Results from the International Society of Pe+diatric Oncology (SIOP) Study SIOPEL-1 and Review of the World Experience Pediat Blood and Cancer 42: 74-83, 2004.
11. Oue T., Fukuzawa M., Kusafuka T., Kohmoto Y., Okada A., Imura K. Transcatheter arterial chemoembolization in the treatment of hepatoblastoma. J Pediatr Surg 33: 1771-1775, 1998.
12. Perilongo G., Shafford E., Maibach R., Aronson D., Brugières L., Brock P., Childs M., Czauderna P., MacKinlay G., Ottej J. B., Pritchardk J., Rondellil I, R., Scopinarom M., Staalmann C. and Plaschkeso J. Risk-adapted treatment for childhood hepatoblastoma final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2 Eur J of Cancer 40: 411-421, 2004.
13. Pritchard J., Brown J., Shafford E., Perilongo G., Brock P., Dicks-Mireaux C., Keeling J., Phillips A., Vos A., Plaschkes J. Cisplatin, doxorubicin and delayed surgery for childhood hepatoblastoma: a successful approach-results of the first prospective study of the International Society of Paediatric Oncology. J Clin Oncol 18: 3819-3828, 2000.
14. Sasaki F., Matsunaga T., Iwafuchi M., Hayashi Y., Ohkawa H., Ohira M., Okamatsu T., Sugito T., Tsuchida Y., Toyosaka A., Nagahara N., Nishihira H., Hata Y., Uchino J., Misugi K., Ohnuma N. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37: 851-856, 2002.
15. Xianliang H., Jianhong L., Xuewu J. and Zhongxian C. Cure of Hepatoblastoma with Transcatheter Arterial Chemoembolization. J Pediatr Hemato/Oncol 26: 60-63, 2004.